Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,000
Closed -$1.49M 1550
2024
Q4
$1.49M Hold
15,000
0.01% 672
2024
Q3
$1.7M Buy
+15,000
New +$1.78M 0.01% 647

Other funds holding MRK

LMR Partners's MRK Position: Q1 2026 in Review

LMR Partners reduced its Merck (MRK) stake by 90% in Q1 2026, selling an estimated $3.12M and leaving 3,000 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

LMR Partners first reported a position in MRK in Q2 2014 and has held it in 18 quarters since. The position peaked at $4.28M in Q2 2014. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LMR Partners held 3,000 shares of Merck worth $361K as of Q1 2026.
  • LMR Partners sold 27,000 Merck shares in Q1 2026, an estimated $3.12M.
  • Merck made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1118 holding.
  • LMR Partners first reported a position in Merck in Q2 2014 and has held it in 18 quarters since.
  • LMR Partners's Merck position peaked at $4.28M in Q2 2014.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.